MEDICA-16

N/A

Report date: 2022/09/08 10:54:27

Base Information

Drug NameMEDICA-16
Drug Alias Nameβ,β′-Tetramethylhexadecanedioic acid
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesterol synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsObesityHyperlipidemiasInsulin Resistance
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDalhousie UniversityUniversity Of AlbertaThe Hebrew University Hadassah Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDalhousie University
Active IndicationsN/A
Inactive IndicationsObesityHyperlipidemiasInsulin Resistance

Other Information

ATC CodeN/A
Related LinksN/A